← All organizations

OX2 Therapeutics

For profit

Also known as: OX2 Therapeutics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

Last known activity

Nov 30, 2020

Timeline

2010s

Jun 1, 2016
OX2 Therapeutics— Founded

Drugs by trial phase (1 distinct, 1 trials)

Phase 1 (1 own, 0 via acquisition)

hp1a8

Indications

Studied for

Glioblastoma

Recent trials (1)

NCT04642937Lead sponsorPhase 1Nov 30, 2020

Details

Founded: palo alto, ca, US Jun 1, 2016
Last known activity: Nov 30, 2020